Video

Foster a ‘Powerful Team’ Between Patients and Cancer Clinicians

Author(s):

Knowledge and open communication are key to creating a competent cancer care team and ensuring better outcomes.

After receiving a breast cancer diagnosis, there are no wrong questions to ask your care team, explained Dr. Igor Makhlin, assistant professor of medicine at Penn Medicine.

In a recent interview with CURE® ahead of the University of Pennsylvania Abramson Cancer Center’s 25th Life After Breast Cancer conference, Makhlin explained that when patients and their loved ones have a solid understanding of the disease and treatments, they can better express their values and goals, and therefore build a “powerful team” between the patient and clinicians.

Transcription:

One of the main messages I'd love for patients to come away with from conferences like Life After Breast Cancer is that communication is so important, and knowledge is really power. Particularly for patients first appointments, when they're newly diagnosed, whether it's early-stage or metastatic, asking a lot of questions, there is no wrong question to ask. The more you know, and the more you can express what your values are, and what is most important to you, I think that the more powerful the team will be between the patient and the oncology team, and I think the more happy patients will be with the types of treatments they receive and the outcomes. And so really keeping good communication.

The other thing I would say is that this is a really exciting time for breast cancer research and treatment. And we are I feel like just at the tip of the iceberg for where we're headed, which is more targeted therapy, less toxic therapy and hopefully much better outcomes in the near future.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Image of Dr. Salani.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Suneel Kamath is an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, in Ohio.
Image of Dr. Fakih.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
1 expert is featured in this series.
Related Content